GG
GH icon

Gofen & Glossberg’s Guardant Health GH Stock Holding History

Gofen & Glossberg’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,091
Closed -$309K – 625
2021
Q4 		$309K Hold
3,091
– – 0.01% 444
2021
Q3 		$386K Buy
+3,091
New +$367K 0.01% 390

Other funds holding GH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Gofen & Glossberg's GH Position: Q1 2022 in Review

Gofen & Glossberg sold out of Guardant Health (GH) in Q1 2022, closing a stake of 3,091 shares — an estimated $309K sold.

Gofen & Glossberg first reported a position in GH in Q3 2021 and held it in 2 quarters. The position peaked at $386K in Q3 2021. 356 funds tracked by Wall St. Rank hold GH as of Q1 2022.

  • Gofen & Glossberg reported no remaining Guardant Health position as of Q1 2022 after selling out during the quarter.
  • Gofen & Glossberg sold 3,091 Guardant Health shares in Q1 2022, an estimated $309K.
  • Gofen & Glossberg first reported a position in Guardant Health in Q3 2021 and held it in 2 quarters.
  • Gofen & Glossberg's Guardant Health position peaked at $386K in Q3 2021.
  • 356 funds tracked by Wall St. Rank held Guardant Health as of Q1 2022.

Based on Gofen & Glossberg's 13F filing for Q1 2022, filed 14 Apr 2022.